Copyright
©The Author(s) 2023.
World J Hepatol. Jun 27, 2023; 15(6): 850-866
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.850
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.850
Ref. | Purpose | Type of study | Sample size | Conclusion | Setting |
Philips et al[11] | Assessed the use of 5% human fluid for the resuscitation of cirrhotic patients with sepsis | Three hundred-eight patients were divided into two groups | 5% human albumin was safe and more beneficial in correcting hypotension than normal saline | ICU | |
Arabi et al[13] | Assess the use of a low dose of hydrocortisone in cirrhotic patients with sepsis | RCT | 140 patients were 65 excluded, and 39 received hydrocortisone and 36 placeboes | That study did not find mortality improvement with corticosteroids despite hemodynamic improvement. The treatment proposed: Hemodynamic monitoring and management, laboratory test culture, stress ulcer prophylaxis as histamine H2 receptor antagonists, norepinephrine as vasopressors, and empiric antibiotic. The outcome was 28 days of all-cause mortality | ICU |
- Citation: Ndomba N, Soldera J. Management of sepsis in a cirrhotic patient admitted to the intensive care unit: A systematic literature review. World J Hepatol 2023; 15(6): 850-866
- URL: https://www.wjgnet.com/1948-5182/full/v15/i6/850.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i6.850